Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Fostering Collabo rative Rese Fostering a robust research environment through collaboration In April, the Forum held a public meeting to explore ways to streamline the process by which universi- ties, industry, and government negotiate agreements for research collaboration. The Forum commis- sioned a paper, which resulted in the development of material transfer agreement (MTA) and clinical trial agreement (CTA) templates that could be used to facilitate such negotiations. The NIH Nation- al Center for Research Resources has disseminated these documents for use by collaborating institutions. In another initiative, the Forum established a precompetitive collaboration to better understand drug failures, explore standards for data collection and analysis, and to ultimately foster improved decision- making with respect to research and investments in drug development. Member companies have begun to share and analyze information on late-stage attrition. Lastly, following the IOMâs report on conflict of interest, the Forum began plans for a workshop in 2010 that will explore approaches to imple- menting the conflict of interest guidelines in a way that promotes an open and fair exchange among arch academic and commercial partners to advance human health. FebruaryâââDiscussion Series Meeting JuneâââWorkshop on Breakthrough on Comparative Effectiveness Business Models for Drug Development 2008 AprilâââDiscussion Series JuneâââDrug Failures on Science at the FDA Workgroup launched
Fostering Collabo rative Rese Material Transfer and Clinical Trial Agreements In an effort to streamline the process of negotiations between universi- ties, industry, and government, the Forum explored the use of mate- rial transfer agreement/clinical trial agreement (MTA/CTA) templates during a workshop in April 2009. A paper commissioned by the Forum resulted in a set of templates that have been widely-disseminated by NIH and others. They can be downloaded from the Forum website (www.iom.edu/CTA-MTA). Forum Member Barbara Alving, NCRR arch Susan Ehringhouse, AAMC, and Bernie Lo, UCSF JulyâââJeff Drazen OctoberâââWorkshop on Accelerating the appointed co-chair Development of Biomarkers for Drug Safety August 3âââPsychiatric drug NovemberâââWorkshop Series on the Threat development papers are published of Multidrug-Resistant Tuberculosis launched